Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Friday, April 19, 2024 | Back issues
Courthouse News Service Courthouse News Service

Big Pharma

NEWARK, N.J. (CN) - Seeking to monopolize the treatment market for heroin and opioid addiction, Reckitt Benckiser Pharmaceuticals, now known as Indivior, are blocking drugmakers from introducing a generic version of Suboxone, a competitor claims in a federal complaint.

The drug's active ingredients, buprenorphine and naloxone, are also known as Bu-Na.

Categories / Uncategorized

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...